Here’s what Cannabiz Australia are saying..
THC Global Group is rebranding and expanding in 2021, with plans to rename itself Epsilon Healthcare as part of a shift into a broader range of healthcare and pharmaceutical products.
These changes come after the surprise departure of former CEO Ken Charteris in September this year with CFO Jarrod White (pictured) taking on the CEO role in an acting capacity.
The name change will go before shareholders at a meeting in December.
The company is also planning to discontinue the production of its CanndeoCare branded medicines in early 2021 in favour of contract manufacturing at its Southport facility, and is looking at selling off its Canadian assets, including a hydroponics equipment distributor.
Read the full article.
In the meantime the website is still presenting thus….